Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05425862 · SUSPENDED
Trial details
- NCT number
- NCT05425862
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-21
- Primary completion
- 2024-07-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.